Heidi Fields - May 25, 2022 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role: Director
Signature: /s/ Larry Miller, Attorney-in-Fact for Heidi Kunz
Stock symbol: PHAT
Transactions as of: May 25, 2022
Transactions value $: $0
Form type: 4
Date filed: 5/27/2022, 04:43 PM
Previous filing: Mar 21, 2022
Next filing: Jun 14, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PHAT	Stock Option (Right to Buy)	Award	$0	+15K		$0.00	15K	May 25, 2022	Common Stock	15K	$7.40	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.